Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups-Reference-Cited by-同舟云学术

Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups

Published:2021-06-18 Issue:7 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Narasimhan Madhusudhanan¹,Mahimainathan Lenin¹,Araj Ellen¹,Clark Andrew E.¹,Markantonis John¹,Green Allen¹,Xu Jing¹,SoRelle Jeffrey A.¹,Alexis Charles¹,Fankhauser Kimberly¹,Parikh Hiren¹,Wilkinson Kathleen²,Reczek Annika²,Kopplin Noa²,Yekkaluri Sruthi²,Balani Jyoti¹,Thomas Abey²,Singal Amit G.²,Sarode Ravi¹²,Muthukumar Alagarraju¹^ORCID

Affiliation:

1. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

2. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Abstract

The coronavirus disease 19 (COVID-19) pandemic continues to impose a significant burden on global health infrastructure. While identification and containment of new cases remains important, laboratories must now pivot and consider an assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity in the setting of the recent availability of multiple COVID-19 vaccines.

Funder

The State of Texas, Tarrant County, Dallas County, and the City of Dallas, The City of Fort Worth

W.W. Caruth Jr. Fund at Communities Foundation of Texas

Lyda Hill Foundation

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00388-21

Reference20 articles.

1. Interpreting Diagnostic Tests for SARS-CoV-2

2. Virological assessment of hospitalized patients with COVID-2019

3. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients

4. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

5. Clinical and Laboratory Standards Institute. 2014. Evaluation of precision of quantitative measurement procedures, 3rd ed. CLSI EPO5-A3. Clinical and Laboratory Standards Institute, Wayne, PA.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-SARS-CoV-2 IgG antibody after the second and third mRNA vaccinations in staff and residents in a nursing home with a previous COVID-19 outbreak in Niigata, Japan;Journal of Infection and Chemotherapy;2024-02

2. Development and Validation of a Highly Sensitive Multiplex Immunoassay for SARS-CoV-2 Humoral Response Monitorization: A Study of the Antibody Response in COVID-19 Patients with Different Clinical Profiles during the First and Second Waves in Cadiz, Spain;Microorganisms;2023-12-16

3. Evaluation of two anti-SARS-CoV-2 antibody immunoassays for monitoring patients on pre-exposure prophylaxis;Diagnostic Microbiology and Infectious Disease;2023-12

4. Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers;Vaccine;2023-10

5. Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination;PLOS ONE;2023-09-19